Cedric Hermans: What Is Still To Be Discovered and To Be Redefined in The Treatment of Haemophilia A?
Cedric Hermans, Head of Haemophilia Centre at the Saint-Luc University Hospital, Brussels, shared a post on LinkedIn:
”What is still to be discovered and to be redefined in the treatment of Haemophilia A?
On 3 June, at 16:30 (CET), we invite you to join a webinar dedicated to optimizing protection in people with haemophilia.
With the participation of Dr Maria Elisa Mancuso and Dr Cedric Hermans, this session will address how to improve clinical outcomes and the importance of ongoing innovation in treatment.
It will cover current limitations of therapies, unmet needs, the impact on quality of life, and the most up-to-date evidence, as well as the clinical perspective.
The future starts now—join the webinar!
Registration link: The Persistent Need for Innovation in Haemophilia Treatment and Care.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs